Researchers at the Indian Institute of Technology (IIT) Bombay have developed a novel method of using infra-red technology to rapidly test which patients are most at risk of becoming severely unwell from Covid-19. The study was published in the journal Analytical Chemistry.

This study, is a collaborative effort between IIT-B, Kasturba Hospital in Mumbai, QIMR Berghofer Medical Research Institute in Australia and Agilent Technologies India. It was led by Prof. Sanjeeva Srivastava, head of the Proteomics Facility at the IIT-B. It was primarily funded by India’s Science and Engineering Research Board, the Government of India, and a grant from the IIT.